Lupus nephritis long-term study
Part of Immune system & allergy, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This study follows patients with lupus nephritis (kidney inflammation caused by lupus) over time to learn more about the disease and improve care. You may join if you have had a kidney biopsy confirming lupus nephritis at this hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of lupus nephritis through a kidney biopsy at this hospital.
- You must be 14 years old or older.
- You must agree to participate and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how long kidneys keep working in people with lupus nephritis over 2 and 5 years. It aims to understand what factors affect kidney survival, which may help improve future care.
This study tests a care program for people with lupus-related kidney disease. It uses telemedicine visits to help manage your condition and improve your care.
This trial tests a new treatment for people with lupus nephritis, a type of kidney disease caused by lupus. It may help reduce kidney inflammation and protect kidney function.
This trial tests two biologic drugs (belimumab or telitacicept) compared to a standard treatment (mycophenolate mofetil) for people with active lupus nephritis. The goal is to see if biologics work better at controlling kidney inflammation over 6 months.
This trial tests a new kind of treatment called CRC01, which uses your own immune cells modified to attack and calm the overactive immune system that causes lupus. It's for people with severe lupus that affects the kidneys and hasn't improved with standard therapies, and it aims to reduce disease activity and prevent further damage.
This study looks at blood tests from people hospitalized with active lupus nephritis to see if specific markers (called NLR and CRP/albumin ratio) can predict who might need intensive care or have worse outcomes. If you're going to be in the hospital for lupus nephritis, your participation could help improve care for future patients.
Hear when a new Lupus Nephritis (LN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.